Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Feb 02, 2010	EDAP Reports on FDA Meeting LYON, France, Feb 2, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that the FDA at its meeting on January 28, 2010 confirmed the recommendations of the Gastroenterology and Urology Devices Panel of the Medical	View HTML EDAP Reports on FDA Meeting 14.2 KB
Toggle Summary Jan 25, 2010	EDAP Continues FDA Discussion on U.S. ENLIGHT Trial Protocol LYON, France, Jan 25, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that a meeting with the U.S. Food and Drug Administration (FDA) has been scheduled for later this month.	View HTML EDAP Continues FDA Discussion on U.S. ENLIGHT Trial Protocol 13.8 KB
Toggle Summary Jan 06, 2010	EDAP Appoints U.S. Vice President of Sales and Marketing Enhances Strategy to Drive U.S. Sonolith I-Sys Device Sales	View HTML EDAP Appoints U.S. Vice President of Sales and Marketing 14.7 KB
Toggle Summary Dec 17, 2009	EDAP Continues to Expand Ablatherm-HIFU Installed Base Dec 17, 2009 (GlobeNewswire via COMTEX News Network) -- Secures Two Ablatherm-HIFU Device Sales in Europe Finalizing Additional Sales LYON, France, Dec. 17, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that two major hospitals in	View HTML EDAP Continues to Expand Ablatherm-HIFU Installed Base 15.3 KB
Toggle Summary Dec 16, 2009	EDAP Reports on FDA Panel Meeting LYON, France, Dec 16, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that the Company attended the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee Meeting of the U.S.	View HTML EDAP Reports on FDA Panel Meeting 14.5 KB
Toggle Summary Nov 17, 2009	EDAP Reports Third Quarter 2009 Financial Results Highlights: , Nov 17, 2009 (GlobeNewswire via COMTEX News Network) -- Total revenues increased 19.8% for the first nine months of 2009 -- Ablatherm- HIFU revenue per procedure (RPP) treatments increased 36.7% for the first nine months of 2009 -- Sonolith I-Sys Lithotripter received U.S.	View HTML EDAP Reports Third Quarter 2009 Financial Results 30.8 KB
Toggle Summary Nov 16, 2009	EDAP Appoints Top U.S. Urologist to Lead FDA HIFU Clinical Trial LYON, France, Nov 16, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Dr. Inderbir S. Gill, professor and chairman of the Department of Urology at the Keck School of Medicine of the University of Southern	View HTML EDAP Appoints Top U.S. Urologist to Lead FDA HIFU Clinical Trial 15.5 KB
Toggle Summary Nov 04, 2009	EDAP Announces Webcast and Conference Call of Third Quarter 2009 Results LYON, France, Nov 4, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2009 earnings announcement, which will take place on Tuesday, November 17, 2009, before the opening of	View HTML EDAP Announces Webcast and Conference Call of Third Quarter 2009 Results 13.5 KB
Toggle Summary Oct 14, 2009	EDAP Secures First U.S. Sonolith I-Sys Device Sale Follows Recent FDA 510K Approval	View HTML EDAP Secures First U.S. Sonolith I-Sys Device Sale 14.8 KB
Toggle Summary Oct 13, 2009	EDAP Options Contracts to Trade on NASDAQ OMX Philadelphia Stock Exchange LYON, France, Oct 13, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that options contracts corresponding to the underlying EDAP common stock have been approved for listing on the NASDAQ OMX PHLX (PHLX) options	View HTML EDAP Options Contracts to Trade on NASDAQ OMX Philadelphia Stock Exchange 16.5 KB